UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by First Hawaiian Bank

First Hawaiian Bank decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.5% in the second quarter, Holdings Channel reports. The fund owned 14,160 shares of the healthcare conglomerate’s stock after selling 2,806 shares during the period. First Hawaiian Bank’s holdings in UnitedHealth Group were worth $7,211,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $31,000. Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. Red Tortoise LLC grew its stake in shares of UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 23 shares during the period. Transcendent Capital Group LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,000. Finally, Ruedi Wealth Management Inc. grew its stake in shares of UnitedHealth Group by 58.3% in the 1st quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 28 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $17.06 during midday trading on Friday, hitting $589.83. The stock had a trading volume of 5,094,041 shares, compared to its average volume of 4,453,607. The company has a market capitalization of $542.87 billion, a PE ratio of 36.05, a P/E/G ratio of 1.64 and a beta of 0.59. The stock has a 50 day moving average price of $514.72 and a two-hundred day moving average price of $502.99. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.14 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Barclays increased their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Robert W. Baird increased their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, TD Cowen increased their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $614.17.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.